FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2804221754> ?p ?o ?g. }

• W2804221754 abstract "To evaluate survival data and local tumor control after transarterial chemoembolization in two groups with different embolization protocols for the treatment of HCC patients. Ninty-nine patients (mean age: 63.6 years), 78 male (78.8%) with HCC were repeatedly treated with chemoembolization in 4-week-intervals. Eighty-eight patients had BCLC-Stage-B and in 11 patients, chemoembolization was performed for bridging (BCLC-Stage-A). In total, 667 chemoembolization treatments were performed (mean 6.7 treatments/patient). The administered chemotherapeutic agent included mitomycin. For embolization, lipiodol only (n = 51;51.5%; mean age 63.8 years; 38 male), or lipiodol plus degradable starch microspheres (DSM) (n = 48; 48.5%; mean age 63.4 years; 40 male) were used. The local tumor response was assessed by MRI using Response Evaluation Criteria in Solid Tumors 1.1 (RECIST 1.1). Patient survival times were evaluated using Kaplan-Meier curves and log-rank tests. The local tumor control in the lipiodol-group was: PR (partial response) in 11 (21.6%), SD (stable disease) in 32 (62.7%) and PD (progressive disease) in 8 cases (15.7%). In the lipiodol-DSM-group, PR was seen in 14 (29.2%), SD in 22 (45.8%), and PD in 12 (25.0%) individuals (p = 0.211). The median survival of patients after chemoembolization with lipiodol was 25 months and in the lipiodol-DSM-group 28 months (p = 0.845). Our data suggest a slight benefit of the use of lipiodol and DSM in comparison of using lipiodol only for chemoembolization of HCC in terms of local tumor control and survival data, this trend did not reach the level of significance." @default.
• W2804221754 created "2018-06-01" @default.
• W2804221754 creator A5011341663 @default.
• W2804221754 creator A5022212185 @default.
• W2804221754 creator A5023997179 @default.
• W2804221754 creator A5035318279 @default.
• W2804221754 creator A5062104348 @default.
• W2804221754 creator A5085332516 @default.
• W2804221754 creator A5085804033 @default.
• W2804221754 date "2018-02-14" @default.
• W2804221754 modified "2023-10-11" @default.
• W2804221754 title "Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study" @default.
• W2804221754 cites W1568134792 @default.
• W2804221754 cites W1606190216 @default.
• W2804221754 cites W1964536349 @default.
• W2804221754 cites W1979687370 @default.
• W2804221754 cites W2006375585 @default.
• W2804221754 cites W2011897106 @default.
• W2804221754 cites W2017688048 @default.
• W2804221754 cites W2038409265 @default.
• W2804221754 cites W2044132250 @default.
• W2804221754 cites W2048119106 @default.
• W2804221754 cites W2048282864 @default.
• W2804221754 cites W2056092524 @default.
• W2804221754 cites W2061381829 @default.
• W2804221754 cites W2064604565 @default.
• W2804221754 cites W2071607867 @default.
• W2804221754 cites W2075725415 @default.
• W2804221754 cites W2092570110 @default.
• W2804221754 cites W2103362199 @default.
• W2804221754 cites W2109619567 @default.
• W2804221754 cites W2123945632 @default.
• W2804221754 cites W2128560156 @default.
• W2804221754 cites W2170722580 @default.
• W2804221754 cites W2322468936 @default.
• W2804221754 cites W2323096433 @default.
• W2804221754 cites W2402033414 @default.
• W2804221754 cites W3148676889 @default.
• W2804221754 cites W91288845 @default.
• W2804221754 doi "https://doi.org/10.1186/s12885-018-4099-x" @default.
• W2804221754 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5813391" @default.
• W2804221754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29444653" @default.
• W2804221754 hasPublicationYear "2018" @default.
• W2804221754 type Work @default.
• W2804221754 sameAs 2804221754 @default.
• W2804221754 citedByCount "17" @default.
• W2804221754 countsByYear W28042217542018 @default.
• W2804221754 countsByYear W28042217542019 @default.
• W2804221754 countsByYear W28042217542020 @default.
• W2804221754 countsByYear W28042217542021 @default.
• W2804221754 countsByYear W28042217542022 @default.
• W2804221754 countsByYear W28042217542023 @default.
• W2804221754 crossrefType "journal-article" @default.
• W2804221754 hasAuthorship W2804221754A5011341663 @default.
• W2804221754 hasAuthorship W2804221754A5022212185 @default.
• W2804221754 hasAuthorship W2804221754A5023997179 @default.
• W2804221754 hasAuthorship W2804221754A5035318279 @default.
• W2804221754 hasAuthorship W2804221754A5062104348 @default.
• W2804221754 hasAuthorship W2804221754A5085332516 @default.
• W2804221754 hasAuthorship W2804221754A5085804033 @default.
• W2804221754 hasBestOaLocation W28042217541 @default.
• W2804221754 hasConcept C126322002 @default.
• W2804221754 hasConcept C126838900 @default.
• W2804221754 hasConcept C127413603 @default.
• W2804221754 hasConcept C141071460 @default.
• W2804221754 hasConcept C189942447 @default.
• W2804221754 hasConcept C2776035437 @default.
• W2804221754 hasConcept C2776231280 @default.
• W2804221754 hasConcept C2776694085 @default.
• W2804221754 hasConcept C2777546739 @default.
• W2804221754 hasConcept C2778019345 @default.
• W2804221754 hasConcept C2778448856 @default.
• W2804221754 hasConcept C2778822529 @default.
• W2804221754 hasConcept C2779338040 @default.
• W2804221754 hasConcept C2779984678 @default.
• W2804221754 hasConcept C2780140570 @default.
• W2804221754 hasConcept C2989005 @default.
• W2804221754 hasConcept C42360764 @default.
• W2804221754 hasConcept C71924100 @default.
• W2804221754 hasConcept C90924648 @default.
• W2804221754 hasConceptScore W2804221754C126322002 @default.
• W2804221754 hasConceptScore W2804221754C126838900 @default.
• W2804221754 hasConceptScore W2804221754C127413603 @default.
• W2804221754 hasConceptScore W2804221754C141071460 @default.
• W2804221754 hasConceptScore W2804221754C189942447 @default.
• W2804221754 hasConceptScore W2804221754C2776035437 @default.
• W2804221754 hasConceptScore W2804221754C2776231280 @default.
• W2804221754 hasConceptScore W2804221754C2776694085 @default.
• W2804221754 hasConceptScore W2804221754C2777546739 @default.
• W2804221754 hasConceptScore W2804221754C2778019345 @default.
• W2804221754 hasConceptScore W2804221754C2778448856 @default.
• W2804221754 hasConceptScore W2804221754C2778822529 @default.
• W2804221754 hasConceptScore W2804221754C2779338040 @default.
• W2804221754 hasConceptScore W2804221754C2779984678 @default.
• W2804221754 hasConceptScore W2804221754C2780140570 @default.
• W2804221754 hasConceptScore W2804221754C2989005 @default.
• W2804221754 hasConceptScore W2804221754C42360764 @default.
• W2804221754 hasConceptScore W2804221754C71924100 @default.
• W2804221754 hasConceptScore W2804221754C90924648 @default.
• W2804221754 hasIssue "1" @default.

• next